Glycogen synthase kinase 3
From Proteopedia
(Difference between revisions)
| Line 24: | Line 24: | ||
**[[1gng]] - hGSK-3 β + Frattide peptide<br /> | **[[1gng]] - hGSK-3 β + Frattide peptide<br /> | ||
| - | **[[1q4l]], [[1uv5]], [[1q5k]], [[1r0e]], [[2o5k]], [[2ow3]], [[3du8]], [[3f7z]], [[3f88]], [[3i4b]], [[3gb2]], [[3l1s]], [[3q3b]], [[3zrk]], [[3zrl]], [[3zrm]], [[3sd0]], [[4dit]], [[4afj]], [[4acc]], [[4acd]], [[4acg]], [[4ach]], [[3say]], [[4iq6]], [[4j1r]], [[4j71]], [[5k5n]], [[5hlp]], [[5hln]], [[5f94]], [[5f95]] - hGSK-3 β + inhibitor<br /> | + | **[[1q4l]], [[1uv5]], [[1q5k]], [[1r0e]], [[2o5k]], [[2ow3]], [[3du8]], [[3f7z]], [[3f88]], [[3i4b]], [[3gb2]], [[3l1s]], [[3q3b]], [[3zrk]], [[3zrl]], [[3zrm]], [[3sd0]], [[4dit]], [[4afj]], [[4acc]], [[4acd]], [[4acg]], [[4ach]], [[3say]], [[4iq6]], [[4j1r]], [[4j71]], [[5k5n]], [[5hlp]], [[5hln]], [[5f94]], [[5f95]], [[5kpk]], [[5kpl]], [[5kpm]] - hGSK-3 β + inhibitor<br /> |
| + | **[[5t31]] - hGSK-3 β (mutant) + inhibitor<br /> | ||
**[[1pyx]], [[1j1b]] - hGSK-3 β + AMPPNP<br /> | **[[1pyx]], [[1j1b]] - hGSK-3 β + AMPPNP<br /> | ||
**[[1j1c]] - hGSK-3 β + ADP<br /> | **[[1j1c]] - hGSK-3 β + ADP<br /> | ||
| Line 35: | Line 36: | ||
**[[2jld]] - hGSK-3 β + Ru complex + peptide<br /> | **[[2jld]] - hGSK-3 β + Ru complex + peptide<br /> | ||
| - | **[[3zdi]] - hGSK-3 β + Axin peptide + inhibitor<br /> | + | **[[3zdi]], [[6b8j]] - hGSK-3 β + Axin peptide + inhibitor<br /> |
| + | **[[5oy4]] - hGSK-3 β + FRAT-1 peptide + inhibitor<br /> | ||
**[[4nm5]], [[4nm7]] - hGSK-3 β + Axin peptide + WNT receptor LRP6 peptide<br /> | **[[4nm5]], [[4nm7]] - hGSK-3 β + Axin peptide + WNT receptor LRP6 peptide<br /> | ||
}} | }} | ||
Revision as of 09:40, 4 June 2018
| |||||||||||
3D structures of glycogen synthase kinase 3
Updated on 04-June-2018
References
- ↑ Forde JE, Dale TC. Glycogen synthase kinase 3: a key regulator of cellular fate. Cell Mol Life Sci. 2007 Aug;64(15):1930-44. PMID:17530463 doi:http://dx.doi.org/10.1007/s00018-007-7045-7
- ↑ Jope RS, Roh MS. Glycogen synthase kinase-3 (GSK3) in psychiatric diseases and therapeutic interventions. Curr Drug Targets. 2006 Nov;7(11):1421-34. PMID:17100582
- ↑ Atilla-Gokcumen GE, Di Costanzo L, Meggers E. Structure of anticancer ruthenium half-sandwich complex bound to glycogen synthase kinase 3beta. J Biol Inorg Chem. 2010 Sep 7. PMID:20821241 doi:10.1007/s00775-010-0699-x

